Investment & Partnership Panel – Accelerating Innovation in Conjugate Therapeutics

Hear directly from VCs and pharma BD leaders on what data packages, formats, and strategies attract investment:

• What pharma wants: therapeutic index, MoA clarity, and early efficacy signals
• Pre-IND vs. Phase I: where investors draw the line on risk
• Collaboration models and platform licensing strategies

Speakers:

Juanjo Cragnolini

Oncology S&E lead

Takeda Pharmaceutical

Carla Bauer

Director, Search & Evaluation, Business Development & Licensing

Merck

Vikas Goyal

Partner, Growth Investments

Longwood Funds

Hong Xin

Senior Director, Oncology Scientific Innovation

Johnson & Johnson

Xiaodong Zhang

Director, Search & Evaluation, Oncology and Hematology

Novartis

Bob Lutz

Chief Development Officer

Synthis Therapeutics

James Italia

Director - Search, Evaluation, Research & Technologies, GBD

Daiichi Sankyo